The Impact of Surgery on Long-Term Survival of Patients with Primary Gastric Diffuse Large B-Cell Lymphoma: A SEER Population-Based Study.
Ju-Li LinJian-Xian LinPing LiJian-Wei XieJia-Bin WangJun LuQi-Yue ChenLong-Long CaoChao-Hui ZhengChang-Ming HuangPublished in: Gastroenterology research and practice (2019)
A prognostic model was constructed based on the independent risk factors of age, tumor stage, and chemotherapy. The prognostic model indicated that low-risk patients (age < 75 years, stage I/II, with/without chemotherapy) undergoing surgical treatment may benefit from long-term survival, while intermediate- and high-risk patients (age ≥ 75 years, stage I/II, with/without chemotherapy or III/IV patients, with/without chemotherapy) gain no significant benefit from surgery.
Keyphrases
- end stage renal disease
- diffuse large b cell lymphoma
- ejection fraction
- risk factors
- newly diagnosed
- chronic kidney disease
- minimally invasive
- locally advanced
- prognostic factors
- peritoneal dialysis
- coronary artery bypass
- radiation therapy
- patient reported outcomes
- coronary artery disease
- acute coronary syndrome
- chemotherapy induced
- percutaneous coronary intervention